1 year return (CAGR)
-74.81%
Propanc Biopharma, Inc. Common Stock Exchange (NASDAQ, USD)
PPCB
-
+0.01 (+1.51%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-93.67%
5 year return (CAGR)
-95.22%
10 year return (CAGR)
-89.02%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
3.16M
Price/Sales
-
Ent value
5.70M
Price/Book
0.34
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-16.09%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-84.91%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreDownside potential
Loading...
Downside potential data
| PPCB | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.24% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 7 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -84.36% | -10.67% |
| Avg time to new high | 8 days | 12 days |
| Max time to new high | 2355 days | 1805 days |
News
